Sing George L's Form 4 filing
Regeneron Pharmaceuticals, Inc. (REGN) · filed Aug 30, 2021
- Accession no.
- 0001237899-21-000020
- Filed
- Aug 30, 2021
- Trade date
- Aug 26-30, 2021
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market sales total $1.14M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sing George LCIK 0001225471 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 30, 2021 | Common Stock | SSaleDisposed | −500 | $670.00 | −$335,000 | 43,358 | Direct | |
| Aug 30, 2021 | Common Stock | SSaleDisposed | −500 | $675.00 | −$337,500 | 42,858 | Direct | |
| Aug 26, 2021 | Common Stock | SSaleDisposed | −150 | $672.00 | −$100,800 | 1,000 | Indirect | |
| Aug 30, 2021 | Common Stock | SSaleDisposed | −250 | $670.00 | −$167,500 | 750 | Indirect | |
| Aug 30, 2021 | Common Stock | SSaleDisposed | −300 | $672.00 | −$201,600 | 1,750 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.